Jul 7, 2026 08:00AM
Jul 7, 2026 08:00AM
Jun 29, 2026 04:49PM
Jun 29, 2026 04:30PM
Jun 29, 2026 04:30PM
Jun 22, 2026 08:01AM
Jun 22, 2026 08:00AM Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of
May 7, 2026 08:00AM
Apr 14, 2026 03:32PM
Apr 14, 2026 11:46AM
Apr 14, 2026 11:38AM
Apr 14, 2026 07:30AM
Apr 14, 2026 07:30AM
Apr 13, 2026 08:01AM Praxis to present ulixacaltamide essential tremor data at AAN 2026
Apr 13, 2026 08:00AM
Apr 9, 2026 04:29PM
Apr 6, 2026 08:00AM
Apr 6, 2026 08:00AM
Mar 30, 2026 04:01PM
Mar 30, 2026 04:01PM
Feb 19, 2026 07:30AM Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Feb 10, 2026 06:39AM
Jan 13, 2026 04:30PM
Jan 13, 2026 04:30PM
Jan 12, 2026 08:04AM
Jan 12, 2026 08:00AM
Jan 2, 2026 08:56AM
Dec 31, 2025 07:16AM TD Cowen: 'We view yesterday's announcement as highly positive for PRAX'
Dec 30, 2025 06:37AM
Dec 29, 2025 09:23AM
Dec 29, 2025 08:51AM
Dec 29, 2025 08:01AM
Dec 29, 2025 08:00AM
Dec 22, 2025 07:06AM
Dec 15, 2025 04:35AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $750 (from $250) at Oppenheimer
Dec 11, 2025 08:02AM
Dec 11, 2025 08:00AM
Dec 9, 2025 04:01PM
Dec 9, 2025 04:01PM
Dec 8, 2025 08:00AM
Dec 8, 2025 07:10AM
Dec 8, 2025 06:30AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $760 at Guggenheim, 'remains one of our top picks for 2025'
Dec 5, 2025 07:20AM
Dec 5, 2025 07:08AM
Dec 5, 2025 06:44AM
Dec 4, 2025 04:12PM
Dec 4, 2025 04:10PM
Dec 4, 2025 04:01PM
Dec 4, 2025 04:01PM Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
Nov 24, 2025 04:01PM

326,538 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All